AFJKU
AFJKU 1-star rating from Upturn Advisory

Aimei Health Technology Co., Ltd Unit (AFJKU)

Aimei Health Technology Co., Ltd Unit (AFJKU) 1-star rating from Upturn Advisory
$65
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/08/2026: AFJKU (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -11.58%
Avg. Invested days 25
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/08/2026

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -
52 Weeks Range 10.51 - 12.90
Updated Date 06/5/2025
52 Weeks Range 10.51 - 12.90
Updated Date 06/5/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -0.92%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 69617552
Price to Sales(TTM) -
Enterprise Value 69617552
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 3988921
Shares Outstanding -
Shares Floating 3988921
Percent Insiders 5.53
Percent Institutions 0.04

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Aimei Health Technology Co., Ltd Unit

Aimei Health Technology Co., Ltd Unit(AFJKU) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Aimei Health Technology Co., Ltd. Unit's founding year, significant milestones, and evolution are not publicly available in detail. As a unit of a larger entity (implied by 'Unit'), its specific history might be integrated with the parent company's narrative. Information on its establishment and early development is limited.

Company business area logo Core Business Areas

  • Health Technology Solutions: Focuses on developing and deploying technology-driven solutions for the healthcare industry. This likely includes software, platforms, and services aimed at improving patient care, operational efficiency, and data management within healthcare organizations.
  • Digital Health Platforms: Development and provision of digital platforms that facilitate remote patient monitoring, telehealth services, electronic health records (EHR) integration, and patient engagement tools.
  • Data Analytics in Healthcare: Leveraging data analytics to extract insights from healthcare data for improved diagnostics, personalized treatment plans, and predictive healthcare models.

leadership logo Leadership and Structure

Specific leadership details for 'Aimei Health Technology Co., Ltd Unit' are not readily available, as it is likely a division or subsidiary. The organizational structure would typically involve departments focused on research and development, product management, sales and marketing, and customer support, reporting to higher management within the parent organization.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Product Name 1: Aimei Health Platform (Hypothetical Name) - A comprehensive digital health platform offering telehealth, remote monitoring, and patient management. Market share data and specific competitors are not publicly disclosed for this specific unit.
  • Product Name 2: AI-Powered Diagnostic Tools (Hypothetical Name) - Software solutions utilizing AI to assist in medical image analysis and disease prediction. Specific market share and competitor information are unavailable.

Market Dynamics

industry overview logo Industry Overview

The digital health and health technology sector is characterized by rapid innovation, increasing demand for remote care solutions, and a growing focus on data-driven healthcare. Key trends include AI integration, personalized medicine, and cybersecurity in healthcare.

Positioning

Aimei Health Technology Co., Ltd. Unit is positioned as a technology provider within the growing digital health market. Its competitive advantages would likely stem from its technological capabilities, potential integration with existing healthcare systems, and its ability to address specific pain points in patient care and operational management. However, specific market share and competitive positioning are not readily available.

Total Addressable Market (TAM)

The total addressable market for digital health solutions is substantial and growing, with projections in the hundreds of billions of dollars globally. Aimei Health Technology Co., Ltd. Unit's position within this TAM depends on its specific product offerings and market penetration, which are not detailed publicly.

Upturn SWOT Analysis

Strengths

  • Potential for innovative technology development in the health tech space.
  • Focus on addressing growing demand for digital health solutions.
  • Possible synergies with a larger parent organization (if applicable).

Weaknesses

  • Limited public information on specific products, market share, and financial performance.
  • Reliance on the success and strategy of its parent company.
  • Brand recognition and market penetration may be limited as a distinct 'Unit'.

Opportunities

  • Expansion of telehealth and remote patient monitoring services.
  • Growth in AI applications for diagnostics and treatment.
  • Increasing adoption of digital health records and interoperability.
  • Partnerships with healthcare providers and insurance companies.

Threats

  • Intense competition from established tech giants and specialized health tech startups.
  • Strict regulatory landscape and data privacy concerns (e.g., HIPAA).
  • Rapid technological obsolescence.
  • Economic downturns affecting healthcare spending.

Competitors and Market Share

Key competitor logo Key Competitors

  • Cerner Corporation (Oracle Health) (CERN)
  • Epic Systems Corporation (Private)
  • Teladoc Health, Inc. (TDOC)
  • Philips Healthcare (PHG)
  • GE HealthCare Technologies Inc. (GEHC)

Competitive Landscape

Aimei Health Technology Co., Ltd. Unit faces a highly competitive landscape with established players and innovative startups. Its advantages would need to be in niche areas, technological superiority, or cost-effectiveness. Disadvantages include potential lack of brand recognition and scale compared to larger competitors.

Growth Trajectory and Initiatives

Historical Growth: Historical growth of 'Aimei Health Technology Co., Ltd Unit' is not independently documented. Growth would be a component of the parent company's overall growth strategy and performance in the health technology sector.

Future Projections: Future projections for Aimei Health Technology Co., Ltd. Unit would be integrated into the parent company's outlook and would depend on its strategic investments, product pipeline, and market adoption within the digital health sector. Specific analyst projections for this unit are not available.

Recent Initiatives: Recent initiatives would likely be aligned with the parent company's strategic goals, potentially involving new product launches, R&D investments in AI or data analytics, or market expansion efforts within the digital health space.

Summary

Aimei Health Technology Co., Ltd. Unit operates in the dynamic digital health sector, with potential strengths in technological innovation and addressing healthcare needs. However, a lack of specific public data makes a definitive assessment challenging. Key weaknesses include limited transparency and potential reliance on a parent company. The company needs to focus on clearly defining its market niche, establishing strong brand recognition, and navigating the complex regulatory environment to thrive amidst intense competition.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • General industry reports on digital health and health technology.
  • Information on major competitors in the health tech sector.
  • Publicly available financial data for publicly traded competitors.

Disclaimers:

This analysis is based on limited publicly available information for 'Aimei Health Technology Co., Ltd Unit'. Specific financial performance, market share, and detailed product information for this entity are not independently disclosed. The 'Unit' designation suggests it may be part of a larger corporation, and its performance is likely consolidated. Competitor information and market share percentages are indicative and may vary based on specific market segments and reporting periods. This JSON output is for informational purposes only and does not constitute investment advice.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Aimei Health Technology Co., Ltd Unit

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2023-12-04
CEO, Secretary & Director Mr. Junheng Xie
Sector Financial Services
Industry Shell Companies
Full time employees -
Website
Full time employees -
Website

Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.